Ratings AgroGalaxy Participações S.A.

Equities

AGXY3

BRAGXYACNOR4

Market Closed - Sao Paulo Other stock markets 16:06:00 2024-04-26 EDT			5-day change	1st Jan Change
1.73 ^BRL	-2.81%		-3.89%	-52.34%

03-27	Transcript : AgroGalaxy Participações S.A., Q4 2023 Earnings Call, Mar 27, 2024
03-26	AgroGalaxy Participações S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Summary

The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

Its low valuation, with P/E ratio at 4.44 and 1.92 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.17 for the 2024 fiscal year.
The company appears to be poorly valued given its net asset value.
This company will be of major interest to investors in search of a high dividend stock.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
The company has insufficient levels of profitability.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Home Improvement Products & Services Retailers

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
AGROGALAXY PARTICIPAÇÕES S.A.	-52.34%	56.51M		-
GROWGENERATION CORP.	-11.55%	137M		C-
CALLOWAY'S NURSERY, INC.	-16.17%	50.48M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes